Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CERO |
---|---|---|
09:32 ET | 41497 | 0.242601 |
09:33 ET | 28177 | 0.242251 |
09:35 ET | 455598 | 0.2408 |
09:37 ET | 23165 | 0.248199 |
09:39 ET | 72928 | 0.2456 |
09:42 ET | 83009 | 0.2521 |
09:44 ET | 37638 | 0.2521 |
09:46 ET | 106690 | 0.2616 |
09:48 ET | 34265 | 0.2644 |
09:50 ET | 56444 | 0.2643 |
09:51 ET | 169574 | 0.2687 |
09:53 ET | 218669 | 0.2711 |
09:55 ET | 238985 | 0.2675 |
09:57 ET | 72689 | 0.2613 |
10:00 ET | 70963 | 0.265 |
10:02 ET | 90348 | 0.2649 |
10:04 ET | 52876 | 0.269 |
10:06 ET | 475255 | 0.276 |
10:08 ET | 859306 | 0.281799 |
10:09 ET | 220566 | 0.2802 |
10:11 ET | 607479 | 0.278 |
10:13 ET | 255383 | 0.271 |
10:15 ET | 128784 | 0.269 |
10:18 ET | 60060 | 0.2708 |
10:20 ET | 52642 | 0.2695 |
10:22 ET | 113951 | 0.2657 |
10:24 ET | 40260 | 0.2697 |
10:26 ET | 115632 | 0.2626 |
10:27 ET | 45046 | 0.262451 |
10:29 ET | 157992 | 0.2573 |
10:31 ET | 109131 | 0.2574 |
10:33 ET | 41911 | 0.2586 |
10:36 ET | 114517 | 0.2644 |
10:38 ET | 91412 | 0.267 |
10:40 ET | 13335 | 0.2659 |
10:42 ET | 37472 | 0.264699 |
10:44 ET | 99762 | 0.2665 |
10:45 ET | 213016 | 0.2607 |
10:47 ET | 133535 | 0.264 |
10:49 ET | 41856 | 0.2672 |
10:51 ET | 40838 | 0.2662 |
10:54 ET | 4230 | 0.2661 |
10:56 ET | 101249 | 0.25965 |
10:58 ET | 3071 | 0.2623 |
11:00 ET | 2691 | 0.2621 |
11:02 ET | 17660 | 0.263999 |
11:03 ET | 5912 | 0.2639 |
11:05 ET | 24955 | 0.266 |
11:07 ET | 29752 | 0.2626 |
11:09 ET | 2493 | 0.2601 |
11:12 ET | 19531 | 0.2626 |
11:14 ET | 8748 | 0.262201 |
11:16 ET | 3749 | 0.2647 |
11:18 ET | 5266 | 0.2608 |
11:20 ET | 658 | 0.2613 |
11:21 ET | 4066 | 0.264099 |
11:23 ET | 11000 | 0.2638 |
11:25 ET | 64950 | 0.2675 |
11:27 ET | 4489 | 0.267 |
11:30 ET | 900 | 0.2671 |
11:32 ET | 41374 | 0.268 |
11:34 ET | 129577 | 0.27575 |
11:36 ET | 75532 | 0.2745 |
11:38 ET | 72621 | 0.2732 |
11:39 ET | 138578 | 0.275 |
11:41 ET | 35432 | 0.2751 |
11:43 ET | 134892 | 0.2711 |
11:45 ET | 20001 | 0.275 |
11:48 ET | 17997 | 0.2746 |
11:50 ET | 76533 | 0.2771 |
11:52 ET | 221697 | 0.2786 |
11:54 ET | 94123 | 0.282 |
11:56 ET | 22979 | 0.2827 |
11:57 ET | 137065 | 0.2796 |
11:59 ET | 177891 | 0.2811 |
12:01 ET | 358283 | 0.2823 |
12:03 ET | 56566 | 0.281 |
12:06 ET | 161445 | 0.284 |
12:08 ET | 84452 | 0.2847 |
12:10 ET | 189038 | 0.283599 |
12:12 ET | 215087 | 0.2801 |
12:14 ET | 49226 | 0.2784 |
12:15 ET | 45833 | 0.2802 |
12:17 ET | 55376 | 0.2834 |
12:19 ET | 28327 | 0.283599 |
12:21 ET | 61562 | 0.2835 |
12:24 ET | 25298 | 0.2845 |
12:26 ET | 54280 | 0.283201 |
12:28 ET | 10444 | 0.2832 |
12:30 ET | 36371 | 0.281 |
12:32 ET | 20840 | 0.2811 |
12:33 ET | 11247 | 0.2838 |
12:35 ET | 359067 | 0.2712 |
12:37 ET | 53558 | 0.272901 |
12:39 ET | 7155 | 0.2741 |
12:42 ET | 4192 | 0.2748 |
12:44 ET | 16189 | 0.273599 |
12:46 ET | 2174 | 0.273651 |
12:48 ET | 2900 | 0.2731 |
12:50 ET | 8865 | 0.2733 |
12:51 ET | 52448 | 0.27 |
12:53 ET | 20849 | 0.2701 |
12:55 ET | 19175 | 0.2725 |
12:57 ET | 4808 | 0.2705 |
01:00 ET | 45465 | 0.2701 |
01:02 ET | 9580 | 0.2705 |
01:04 ET | 47788 | 0.2661 |
01:06 ET | 47216 | 0.267 |
01:08 ET | 27214 | 0.2647 |
01:09 ET | 20243 | 0.2657 |
01:11 ET | 33139 | 0.264 |
01:13 ET | 41143 | 0.262301 |
01:15 ET | 92060 | 0.2625 |
01:18 ET | 17016 | 0.2652 |
01:20 ET | 35004 | 0.2622 |
01:22 ET | 8250 | 0.2622 |
01:24 ET | 2294 | 0.2645 |
01:26 ET | 222219 | 0.2561 |
01:27 ET | 119611 | 0.255 |
01:29 ET | 23766 | 0.2532 |
01:31 ET | 4848 | 0.2559 |
01:33 ET | 31100 | 0.253 |
01:36 ET | 32936 | 0.253451 |
01:38 ET | 1445 | 0.2544 |
01:40 ET | 18102 | 0.2525 |
01:42 ET | 289801 | 0.2523 |
01:44 ET | 89108 | 0.2548 |
01:45 ET | 16807 | 0.254 |
01:47 ET | 96204 | 0.2526 |
01:49 ET | 1743 | 0.2521 |
01:51 ET | 26009 | 0.2529 |
01:54 ET | 624 | 0.2511 |
01:56 ET | 3687 | 0.2512 |
01:58 ET | 9212 | 0.2511 |
02:00 ET | 20358 | 0.2521 |
02:02 ET | 52446 | 0.2512 |
02:03 ET | 24918 | 0.2505 |
02:05 ET | 21081 | 0.2502 |
02:07 ET | 18351 | 0.2511 |
02:09 ET | 693 | 0.2508 |
02:12 ET | 8859 | 0.252 |
02:14 ET | 10269 | 0.2511 |
02:16 ET | 4040 | 0.2502 |
02:18 ET | 21137 | 0.25015 |
02:20 ET | 511112 | 0.2485 |
02:21 ET | 11690 | 0.2472 |
02:23 ET | 7344 | 0.2478 |
02:25 ET | 51485 | 0.2452 |
02:27 ET | 21423 | 0.2459 |
02:30 ET | 200 | 0.2476 |
02:32 ET | 8676 | 0.247 |
02:34 ET | 56669 | 0.2463 |
02:36 ET | 76100 | 0.2453 |
02:38 ET | 7561 | 0.2456 |
02:39 ET | 18216 | 0.2459 |
02:41 ET | 1100 | 0.2454 |
02:43 ET | 42704 | 0.24505 |
02:45 ET | 18526 | 0.2459 |
02:48 ET | 3901 | 0.2452 |
02:50 ET | 5800 | 0.2465 |
02:52 ET | 17902 | 0.246699 |
02:54 ET | 56646 | 0.2459 |
02:56 ET | 6086 | 0.2462 |
02:57 ET | 3557 | 0.2452 |
02:59 ET | 7350 | 0.247579 |
03:01 ET | 18830 | 0.2466 |
03:03 ET | 31019 | 0.2458 |
03:06 ET | 48697 | 0.2453 |
03:08 ET | 29963 | 0.2456 |
03:12 ET | 1000 | 0.2458 |
03:15 ET | 45029 | 0.2458 |
03:17 ET | 40400 | 0.245702 |
03:19 ET | 8429 | 0.2474 |
03:21 ET | 3200 | 0.2466 |
03:24 ET | 39268 | 0.2456 |
03:26 ET | 200 | 0.2457 |
03:28 ET | 15802 | 0.2465 |
03:30 ET | 21589 | 0.24565 |
03:32 ET | 26172 | 0.2452 |
03:33 ET | 62922 | 0.2435 |
03:35 ET | 14229 | 0.245 |
03:37 ET | 120334 | 0.241101 |
03:39 ET | 345310 | 0.2383 |
03:42 ET | 39032 | 0.2407 |
03:44 ET | 12319 | 0.2421 |
03:46 ET | 650 | 0.2403 |
03:48 ET | 16825 | 0.2418 |
03:50 ET | 12167 | 0.2408 |
03:51 ET | 11132 | 0.2437 |
03:53 ET | 63374 | 0.243899 |
03:55 ET | 120750 | 0.2416 |
03:57 ET | 32198 | 0.2429 |
04:00 ET | 610656 | 0.2479 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CERo Therapeutics Holdings Inc | 36.6M | -0.7x | --- |
RAPT Therapeutics Inc | 36.6M | -0.4x | --- |
AN2 Therapeutics Inc | 36.8M | -0.6x | --- |
NextCure Inc | 36.1M | -0.6x | --- |
Intensity Therapeutics Inc | 37.2M | -2.3x | --- |
CEL-SCI Corp | 37.2M | -1.0x | --- |
CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company’s proprietary approach to T cell engineering, enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, which is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy. Its cellular immunotherapy platform is focused on redirecting patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating CERo, which is referred to as chimeric engulfment receptor t cells (CER-T). The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $36.6M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 147.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.38 |
Book Value | $-0.92 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.